Reported 5,714,405 shares, up 454,526 (8.6%) from the prior quarter.
Reported value 39.2%; share count 8.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-03-31 | 18738000 |
| 2021-06-30 | 13031000 |
| 2021-09-30 | 13431000 |
| 2021-12-31 | 14180000 |
| 2022-03-31 | 12306000 |
| 2022-06-30 | 23324000 |
| 2022-09-30 | 47502000 |
| 2022-12-31 | 40064556 |
| 2023-03-31 | 38156234 |
| 2023-06-30 | 52529593 |
| 2023-09-30 | 42639782 |
| 2023-12-31 | 26663771 |
| 2024-03-31 | 38745537 |
| 2024-06-30 | 44340781 |
| 2024-09-30 | 61715574 |
| 2024-12-31 | 47840364 |
| 2025-03-31 | 36289444 |
| 2025-06-30 | 46834788 |
| 2025-09-30 | 111400026 |
| 2025-12-31 | 408988860 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Added | 11,514,326 | +3,756,664 (48.4%) | < 0.01% | $408,988,860 | 2026-01-29 | |
| Q3 2025 | Added | 7,757,662 | +1,234,711 (18.9%) | < 0.01% | $111,400,026 | 2025-11-07 | |
| Q2 2025 | Added | 6,522,951 | +464,613 (7.7%) | < 0.01% | $46,834,788 | 2025-08-11 | |
| Q1 2025 | Reduced | 6,058,338 | -75,042 (-1.2%) | < 0.01% | $36,289,444 | 2025-05-09 | |
| Q4 2024 | Added | 6,133,380 | +418,975 (7.3%) | < 0.01% | $47,840,364 | 2025-02-11 | |
| Q3 2024 | Added | 5,714,405 | +454,526 (8.6%) | < 0.01% | $61,715,574 | 2024-11-13 | |
| Q2 2024 | Reduced | 5,259,879 | -505,826 (-8.8%) | < 0.01% | $44,340,781 | 2024-08-13 | |
| Q1 2024 | Added | 5,765,705 | +1,231,050 (27.1%) | < 0.01% | $38,745,537 | 2024-05-10 | |
| Q4 2023 | Added | 4,534,655 | +161,344 (3.7%) | < 0.01% | $26,663,771 | 2024-02-14 | |
| Q3 2023 | Reduced | 4,373,311 | -63,310 (-1.4%) | < 0.01% | $42,639,782 | 2023-11-14 | |
| Q2 2023 | Added | 4,436,621 | +900,362 (25.5%) | < 0.01% | $52,529,593 | 2023-08-14 | |
| Q1 2023 | Added | 3,536,259 | +70,467 (2.0%) | < 0.01% | $38,156,234 | 2023-05-15 | |
| Q4 2022 | Added | 3,465,792 | +282,022 (8.9%) | < 0.01% | $40,064,556 | 2023-02-10 | |
| Q3 2022 | Added | 3,183,770 | +597,966 (23.1%) | < 0.01% | $47,502,000 | 2022-11-14 | |
| Q2 2022 | Added | 2,585,804 | +942,835 (57.4%) | < 0.01% | $23,324,000 | 2022-08-12 | |
| Q1 2022 | Reduced | 1,642,969 | -9,764 (-0.6%) | < 0.01% | $12,306,000 | 2022-05-13 | |
| Q4 2021 | Added | 1,652,733 | +55,617 (3.5%) | < 0.01% | $14,180,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 1,597,116 | -9,673 (-0.6%) | < 0.01% | $13,431,000 | 2021-11-12 | |
| Q2 2021 | Reduced | 1,606,789 | -527,454 (-24.7%) | < 0.01% | $13,031,000 | 2021-08-13 | |
| Q1 2021 | Added | 2,134,243 | +1,275,787 (148.6%) | < 0.01% | $18,738,000 | 2021-05-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
181 managers reported UNUM THERAPEUTICS INC for Q3 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Point72 Asset Management L P | Unchanged | 10,470,398 | 0 | 0.29% | $113,080,298 | 16 qtrs |
| Kynam Capital Management LP | Reduced | 9,239,731 | -20,654 | 7.65% | $99,789,095 | 12 qtrs |
| FMR LLC | Added | 8,319,411 | +625,743 | < 0.01% | $89,849,641 | 12 qtrs |
| BlackRock Inc | New | 7,991,587 | +7,991,587 | < 0.01% | $86,309,140 | 1 qtr |
| COMMODORE CAPITAL LP | Reduced | 7,539,930 | -2,198,070 | 5.09% | $81,431,244 | 16 qtrs |
| TCG Crossover Management LLC | Unchanged | 6,964,375 | 0 | 6.37% | $75,215,250 | 12 qtrs |
| Fairmount Funds Management LLC | Unchanged | 6,225,641 | 0 | 5.45% | $67,236,923 | 16 qtrs |
| VANGUARD GROUP INC This report | Added | 5,714,405 | +454,526 | < 0.01% | $61,715,574 | 16 qtrs |
| VR Adviser LLC | Unchanged | 5,684,167 | 0 | 3.22% | $61,389,004 | 16 qtrs |
| Paradigm Biocapital Advisors LP | Added | 4,609,762 | +985,420 | 1.68% | $49,785,430 | 2 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2024
- Filed
- November 13, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 159,043
- None
- 5,555,362
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.